ETV4 and glioblastoma: As seen in Figures 2A, 3A, patients suffering glioma (GBMLGG), brain low grade glioma (LGG), sarcoma, kidney renal papillary cell carcinoma, head and neck squamous cell carcinoma, GBM, KIRC, mesothelioma (MESO), liver hepatocellular carcinoma (LIHC), and adrenocortical carcinoma (ACC) with high expression of ETV4 had worse overall survival.